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Abstract
The purpose of this study was to describe the imaging features and patterns of disease in patients with recurrent
bladder carcinoma following radical cystectomy.
A retrospective review was made of the CT and MR findings in 42 patients (33 male, 9 female, mean age 65.1 years)
with histologically verified transitional cell carcinoma of the bladder, who developed recurrent disease following
radical cystectomy. Histology confirmed T2 disease in 7 patients, T3 disease in 26 patients and T4 disease in 9
patients. The tumour grade was G3 in 38 patients and G2 in 4 patients. The CT (n = 42) and MR imaging (n = 9)
obtained at disease relapse were reviewed, noting the sites of disease recurrence and their imaging appearances.
The mean time to recurrence following cystectomy was 14.6 months (range 2–50 months). Patients with T2
disease had a significantly longer time to recurrence compared with patients with T3 or T4 disease (22.7 vs. 13.0
months, student t-test, P < 0.05). The most common pattern of recurrence was pelvic lymphadenopathy (55%).
Retroperitoneal lymphadenopathy was common (33%) and was the only site of nodal disease in 10%. Local pelvic
recurrence (45%) appeared as a soft tissue mass, which involved muscle, urethra or vagina. Sites of distant metastasis
included the liver (19%), bone (12%) and lungs (10%). Liver metastasis was associated with nodal disease in the
majority (80%).
The sites of recurrence of bladder cancer following radical cystectomy are described. Pelvic lymph node
involvement is the most frequent site of disease recurrence despite the fact that pelvic lymph node dissection is
performed as part of the standard procedure of radical cystectomy.
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Introduction
Bladder cancer is the most common cancer of the urinary
tract with a peak incidence between the sixth and the sev-
enth decade [1,2]. It is three times more common in men
than women, accounting for 4.5% of all new malignant
neoplasms and 1.9% of cancer deaths in the US [2].
Radical cystectomy is the treatment of choice for
muscle invasive tumours, as it offers the best chance of
cure, but may also be considered as first-line treatment
in cases of superficial tumours with severe anaplasia.
Surgery involves en bloc excision of the bladder, prostate
and seminal vesicles with pelvic nodal dissection.
As the bladder is completely removed at radical
cystectomy, urinary diversion becomes necessary. This
may take the form of cutaneous ureterostomy, ileal
conduit with ureteroileocutaneostomy, ureterosigmoi-
dostomy or orthotopic neobladder reconstruction with
ileal or ileocaecal segments. Orthotopic neobladder
reconstruction is now the procedure of choice if the
urethral sphincter can be conserved at surgery without
compromise to the clearance of tumour [3].
The risk of disease relapse following radical cystec-
tomy is reportedly 5–70%, with the majority occurring
within 2 years of surgery [4,5]. Despite the significant
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risk of relapse, there is a paucity of data describing the
imaging features of recurrent bladder cancer following
surgery. Hence, it was the aim of our study to describe
the imaging features and patterns of disease in patients




Using the hospital information system, a database
search revealed 42 patients with histologically verified
transitional cell carcinoma of the bladder, who developed
recurrent disease following radical cystectomy between
1997 and 2001. There were 33 males and 9 females, with
a mean age of 65.1 years (range 40–80 years). 13 out of
42 patients had received pre-operative radiation treatment
prior to surgery.
Histopathology following radical cystectomy con-
firmed T2 (according to TNM staging system) disease in
7 patients, T3 disease in 26 patients and T4 disease in 9
patients. The tumour grade was grade III in 38 patients
and grade II in 4 patients.
Histological proof of disease relapse was available in
10 patients from percutaneous biopsies. The remaining
32 had presumptive diagnosis of disease relapse based on
the clinical and imaging findings.
Imaging review
A retrospective review was made of the CT (n = 42) and
MR imaging (n = 9) obtained at the time of diagnosis
of disease relapse. Axial CT images were obtained
following intravenous and oral contrast administration,
using a spiral CT system (Siemens’ Somatom, Erhlanger,
Germany) with 8 mm collimation, 8 mm reconstruction
and a scan pitch of 1.5. MR imaging was performed on
a 1.5 T system (Siemens’ Vision, Erhlanger, Germany)
using T1- and T2-weighted axial images, supplemented
with T2-weighted sagittal and coronal images. Dynamic
intravenous gadolinium-enhanced T1-weighted images
were also acquired in 3 patients.
The CT and MR imaging were reviewed to deter-
mine the sites and patterns of disease relapse. For
nodal disease, the appearance, size and location of
lymphadenopathy were recorded. Lymph nodes greater
than 8 mm in size were considered enlarged [6]. For local
pelvic recurrence, the extent and appearance of disease
were evaluated. Involvement of pelvic structures such as
the vagina, urethra, rectum and pelvic sidewall muscles
were noted. The presence and sites of metastatic disease
on imaging were tabulated.
Results
Time to recurrence
The mean time from cystectomy to recurrence was
14.6 months (range 2–50 months). The mean time to
recurrence was shorter for patients with stage T3 or T4
disease (mean = 12.9 months) compared to those with
stage T2 disease (mean = 22.7 months) (P < 0.05,
student’s t-test).
Lymphadenopathy
Despite pelvic nodal dissection, pelvic lymph node was
the most common site of disease relapse (23/42; 55%).
Pelvic nodal relapse was not associated with local pelvic
soft tissue recurrence in the majority (14/23). The mean
nodal size was 3.6 cm (range 2–8 cm) and the nodes were
of homogeneous soft tissue density on CT (Fig. 1).
Figure 1 Pelvic nodal relapse. In this 45-year-
old man with previous cystectomy, note surgical
clips along the pelvic sidewall from previous nodal
dissection. There was urinary diversion by an ileal
conduit (not shown) and the tip of the urinary bag was
visible over the right lower abdominal wall. A 2 cm
left internal iliac lymph node was detected along the
left pelvic sidewall (arrow).
The frequency of pelvic nodal group involvement was
as follows: common iliac nodes (13/42; 31%), external
iliac nodes (11/42; 26%), obturator nodes (11/42; 26%),
hypogastric nodes (4/42; 12%), internal iliac nodes
(4/42; 12%), inguinal nodes (4/42; 12%) and lateral
sacral nodes (2/42; 5%).
Abdominal retroperitoneal lymphadenopathy occurred
in 14/42 (33%). The majority (10/42) of cases had
associated pelvic nodal disease. However, retroperitoneal
lymphadenopathy (Fig. 2) was an isolated finding in 4/42
(10%). Of these, only two cases had received previous
pelvic irradiation.
Local pelvic soft tissue recurrence
Local soft tissue recurrence was detected in 19/42 (45%)
of cases. 11/19 (58%) presented as a circumscribed
soft tissue mass (Fig. 3), while 8/19 (42%) appeared
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as ill-defined soft tissue thickening within the pelvis
(Fig. 4). Involvement of adjacent structures, such as the
vagina (2/19), urethra (2/19), pelvic sidewall (2/19),
anterior abdominal wall (1/19), seminal vesicle (1/19)
and spermatic cord (Fig. 5) (1/19) could be identified
on imaging. Local recurrence was associated with pelvic
lymphadenopathy in 9/19 (47%).
Figure 2 Retroperitoneal lymphadenopathy. In this
60-year-old lady with isolated nodal relapse within the
retroperitoneum, note the circumaortic lymph nodes.
There was mild right hydronephrosis resulting from
the ileal conduit urinary diversion (not shown).
Distant metastasis
Distant metastases were present in 18/42 (47%) patients
at the time of disease of relapse. The most frequent sites
of metastatic disease included the liver (8/42; 19%), the
bones (5/42; 12%) and the lungs (4/42; 10%). Involve-
ment of the peritoneum (1/42), brain (1/42), pancreas
(1/42) and adrenal glands (1/42) was more unusual.
80% (6/8) of patients with liver metastases had
associated nodal disease, either within the pelvis or
retroperitoneum (Fig. 6).
Discussion
Radical cystectomy provides the best treatment option
in patients with muscle invasive bladder carcinoma.
However, patients with extra-vesicular involvement,
nodal metastases, lymphatic or vascular permeation,
pelvic visceral invasion and p53 gene deletion [7], have
a high risk of relapse following radical surgery.
The tumour stage is predictive of the likelihood of
disease recurrence. Slaton et al. [4] found that for stages
T1, T2, and T3 bladder cancer, recurrence occurred in
5, 20 and 40% of patients respectively following surgery.
In another study, the rate of recurrence in patients with
locally advanced disease (37%) was reportedly twice that
of organ-confined disease (18%) [8].
The tumour stage also has an association with the onset
of relapse following surgery. In our study, patients with
stages T3 and T4 disease had a shorter mean time to
recurrence compared to patients with stage T2 disease
(12.9 vs. 22.7 months, P < 0.05). The reported median
time to recurrence following cystectomy is approximately
10–12 months, although this ranges widely between 1
and 100 months [4,5]. The majority of local recurrence
occurs within 2 years of surgery (54–82%) [4,5]. Patients
with a lower stage disease prior to cystectomy recurred
later than those with a higher stage disease. In one
series [4], patients with pT1, pT2 and pT3 disease prior
to cystectomy had a median time to recurrence of 53, 19
and 12 months respectively.
Imaging has an important role in detecting and defining
the sites of recurrent disease. However, familiarity with
the range and variety of post-surgical changes and the
normal appearances of the urinary diversion procedures
is crucial to the interpretation of imaging studies.
Despite pelvic nodal dissection, which is carried out
routinely as part of the radical cystectomy procedure, we
found pelvic lymphadenopathy to be the most frequent
site of relapse, occurring in 55% of our cases. The
majority (14/23) of these cases were not associated with
local soft tissue recurrence. On imaging, pelvic nodal
disease was usually 2 cm or greater in size, and typically
appeared as homogeneous soft tissue attenuation on CT.
Although the external iliac nodes, obturator nodes and
hypogastric lymph nodes are dissected and removed at
surgery, the common iliac chain, the internal iliac chain
and pre-sacral lymph nodes are usually undisturbed. Not
surprisingly, we found that pelvic nodal relapse occurred
most frequently along the common iliac group of lymph
nodes.
Retroperitoneal lymphadenopathy was also common
(33%). Although the majority of cases of retroperitoneal
lymphadenopathy were associated with pelvic nodal
disease, they were an isolated finding in 10%. Only
half of the cases with isolated retroperitoneal nodal
disease had previous history of pelvic irradiation, and no
association could be found between the occurrence of
isolated retroperitoneal lymphadenopathy and previous
pelvic radiotherapy treatment.
Pelvic soft tissue recurrence was found in 45% of our
cases. The majority of pelvic soft tissue recurrence in
our study appeared as a circumscribed soft tissue mass
(58%), although diffuse soft tissue thickening was also
common (42%). Local relapse may be subtle on imaging,
and detection of disease can be made more difficult by the
persistent but variable asymmetrical soft tissue changes
following surgery. Hence, it is imperative to compare
each new scan with previous imaging to scrutinise for
any interval change. In addition, locally recurrent lesions
may be indistinct on CT, resulting in underestimation of
the size and extent of the lesion. In these cases, dynamic
gadolinium-enhanced MR imaging has been proposed as
a method to help distinguish the abnormal tumour tissue
from its surroundings [9].
Ellis et al. [10] reported that recurrence at cystectomy
sites tended to be associated with pelvic lymphadenopa-
Patterns of bladder cancer recurrence 99
(a) (b)
Figure 3 Urethral recurrence. (a) Sagittal and (b) axial T1-weighted images; an intermediate signal mass
arising from the urethra (arrows) due to disease recurrence.
(a) (b)
Figure 4 Pelvic sidewall recurrence. (a) Post-contrast axial CT through the lower pelvis showing ill-defined
soft tissue thickening, which was inseparable from the left obturator internus muscle. (b) A repeat CT through
the same level 3 months later showed an increase in the soft tissue along the left pelvic sidewall. A biopsy
confirmed the presence of disease relapse.
(a) (b)
Figure 5 Left spermatic cord recurrence. (a) T2-weighted axial image showing an orthotopic neobladder
within the pelvis. (b) T2-weighted axial image taken at a lower level showed abnormal thickening of the left
spermatic cord of intermediate signal (arrow). Disease relapse was confirmed at surgery.
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(a) (b)
Figure 6 Liver metastases. (a) Axial CT following intravenous contrast showing multiple low attenuation
metastases within the liver. (b) A CT section taken from the mid-abdomen revealed concomitant bulky left
paraortic nodal disease.
thy and absence of lymphadenopathy in these circum-
stances was unusual. In our study, local recurrent disease
was associated with nodal disease in only 47%, a figure
that is substantially lower than the 80% observed by Ellis
et al. [10].
Bladder cancer can metastasise widely, but their imag-
ing appearances are indistinguishable from metastases
arising from other primary tumours [11,12]. The most
common sites of metastatic disease in our study were the
liver (19%), bones (12%) and lungs (10%). Interestingly,
the majority of patients with liver metastases had
coexisting nodal disease within the pelvis or abdomen.
Most of the cases of relapse in our study have
been detected through surveillance imaging following
cystectomy. However, the usefulness of surveillance CT
after cystectomy remains a subject of controversy. One
report suggests that routine CT surveillance identifies
only 14% of recurrences that are not symptomatic or
apparent on physical examination [5]. Another suggested
that CT could detect up to 30% of those with pelvic
or retroperitoneal recurrence before the development of
symptoms [4].
Montie [13] has proposed a surveillance program for
recurrent transitional cell carcinoma following radical
cystectomy. CT of the abdomen and pelvis at 6, 12, and
24 months is recommended, regardless of the stage of
the primary tumour. Slaton et al. [4], however, advocate
follow-up CT imaging in patients with primary T3
tumour but not in those with lower stage primary disease.
Surveillance CT imaging should include both the pelvis
and abdomen, since recurrence may be apparent only
on the abdominal portion of the scan in up to 13% of
patients [11,12].
Conclusions
The patterns of relapse of bladder cancer following radi-
cal cystectomy have been described. Despite pelvic nodal
dissection, pelvic lymph node was the most frequent
site of disease relapse following radical cystectomy for
transitional cell carcinoma of the bladder. Local pelvic
recurrence was also common, and may present as a
circumscribed mass or diffuse soft tissue thickening.
Retroperitoneal lymphadenopathy was an isolated finding
in 10%. The liver was the most frequent site of metastatic
disease and was usually associated with nodal disease.
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